Ropeginterferon Alfa-2b administered every two weeks for patients with genotype 2 chronic hepatitis CShih-Jer Hsu, Wan‐Long Chuang, Gin‐Ho Lo et al.|Journal of the Formosan Medical Association|2020Cited by 22
Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE studyChen-Hua Liu, Jia‐Horng Kao, Ming‐Lung Yu et al.|Journal of the Formosan Medical Association|2018Cited by 10
Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected PatientsChi-Chieh Yang, Ming‐Lung Yu, Wei-Lun Tsai et al.|PLoS ONE|2015Cited by 9